Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Therapy areas
Immuno-inflammation
Immuno-inflammation
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID
Firstwordpharma News
-
February 22, 2019
Immuno-inflammation
Certolizumab Offers 2-Year Durable Response in Treating Plaque Psoriasis: Presented at AAD
Immuno-inflammation
Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn’s & Colitis Congress
Immuno-inflammation
Merck Eyes Plans Phase III Programs in Prostate Cancer With Keytruda
Immuno-inflammation
DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019
Immuno-inflammation
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval...
Biospace News
-
February 27, 2019
0
Immuno-inflammation
LEO Pharma and Research Project BIOMAP: Towards Personalised Medicine for Inflammatory...
Biospace News
-
April 11, 2019
0
Immuno-inflammation
Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169...
Biospace News
-
March 21, 2019
0
Immuno-inflammation
Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus...
Firstwordpharma News
-
February 26, 2019
0
Immuno-inflammation
Aurinia Receives Notice of Allowance from the US Patent and Trademark...
Biospace News
-
February 25, 2019
0
1
2
3
...
6
Page 1 of 6
- Advertisement -
MOST POPULAR
FDA COVID-19 Vaccine Advisory Committee: Lots of Talk, No Decisions, Some...
October 23, 2020
Parexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Modeling Firm...
February 20, 2020
Bristol Myers Squibb Reports Primary Results of ELOQUENT-1 Study Evaluating Empliciti...
March 9, 2020
After Rocky Road, Karyopharm Wins FDA Approval for Multiple Myeloma Drug
July 4, 2019
Load more
HOT NEWS
Commercial
Ampio Appoints Moss Adams LLP as the Company’s New Independent Auditor
Approval
CTI BioPharma Receives Results of the CHMP Oral Explanation for Pacritinib...
Phase III
Actinium to Announce Interim Results from Pivotal Phase 3 SIERRA Trial...
Therapy areas
Vaccine exemption rates among US kindergartners continue to climb, CDC says...
